We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 564 results
  1. Survivin degradation by bergenin overcomes pemetrexed resistance

    Purpose

    Chemoresistance is a primary factor for treatment failure and tumor recurrence in non-small cell lung cancer (NSCLC) patients. The oncoprotein...

    **aoying Li, Qi Liang, ... Wei Li in Cellular Oncology
    Article 05 August 2023
  2. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression

    The hypomethylation agent decitabine (DAC), in combination with other apoptosis inducers, is considered a potential modality for cancer treatment. We...

    **g-Ting Chiou, Long-Sen Chang in Apoptosis
    Article 08 December 2023
  3. Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation

    Background

    Dedifferentiated liposarcoma (DDLPS), a tumor that lacks effective treatment strategies and is associated with poor outcomes, expresses...

    Valentina Zuco, Sandro Pasquali, ... Nadia Zaffaroni in Journal of Experimental & Clinical Cancer Research
    Article Open access 01 March 2021
  4. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA

    Background

    N 4 -acetylcytidine (ac 4 C) as a significant RNA modification has been reported to maintain the stability of mRNA and to regulate the...

    Chi **, Tuo Wang, ... Yueming Sun in Journal of Experimental & Clinical Cancer Research
    Article Open access 15 December 2022
  5. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma

    Background

    Overexpression of survivin plays a crucial role in tumorigenesis and correlates with poor prognosis in human malignancies. Thus, survivin...

    Ming Li, Feng Gao, ... Wei Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 14 May 2020
  6. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

    Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the remodeling of pulmonary blood vessels. If left unaddressed, PAH...

    Jaydev Dave, Vineeta Jagana, ... Malik Bisserier in Journal of Translational Medicine
    Article Open access 17 July 2023
  7. Epigenetic effects of herbal medicine

    Epigenetic memory is essential for life that governs the predefined functional features of cells. Recent evidence has indicated that the epigenetic...

    Yu-Yao Wu, Yan-Ming Xu, Andy T. Y. Lau in Clinical Epigenetics
    Article Open access 13 May 2023
  8. HDAC6: A unique HDAC family member as a cancer target

    Background

    HDAC6, a structurally and functionally distinct member of the HDAC family, is an integral part of multiple cellular functions such as cell...

    Sumeet Kaur, Prerna Rajoria, Madhu Chopra in Cellular Oncology
    Article 29 August 2022
  9. Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner

    Background

    Breast cancer is the second leading cause of death among women after lung cancer. Despite the improvement in prevention and in therapy,...

    Francesca Giordano, Alessandro Paolì, ... Maria Luisa Panno in Journal of Translational Medicine
    Article Open access 02 March 2023
  10. Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

    Cell cycle and apoptosis regulator 2 (CCAR2), also known as deleted in breast cancer 1 (DBC1), has been recently identified as a master regulator of...

    Hwa ** Kim, Sue ** Moon, Jeong Hoon Kim in Experimental & Molecular Medicine
    Article Open access 01 August 2023
  11. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90

    Posttranslational modification (PTM) and regulation of protein stability are crucial to various biological processes. Histone deacetylase 6 (HDAC6),...

    ** Liu, Ji **ao, ... Yifei Wang in Molecular Medicine
    Article Open access 16 September 2021
  12. Epigenetics as a versatile regulator of fibrosis

    Fibrosis, a process caused by excessive deposition of extracellular matrix (ECM), is a common cause and outcome of organ failure and even death....

    Yangdan Liu, Dongsheng Wen, ... Yifan Zhang in Journal of Translational Medicine
    Article Open access 02 March 2023
  13. Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement

    The Cucurbitaceae family produces a class of secondary metabolites known as cucurbitacins. The eight cucurbitacin subunits are cucurbitacin B, D, E,...

    Ajay Kumar, Bunty Sharma, ... Hardeep Singh Tuli in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 April 2023
  14. The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth

    Programmed death ligand-1 (PD-L1)/PD-1 checkpoint extensively serves as a central mediator of immunosuppression. A tumor-promoting role for abundant...

    Fei-fei Xu, Hui-min Sun, ... Li-hong Ye in Acta Pharmacologica Sinica
    Article 06 April 2021
  15. Sirtuin insights: bridging the gap between cellular processes and therapeutic applications

    The greatest challenges that organisms face today are effective responses or detection of life-threatening environmental changes due to an obvious...

    Shagufta Kamal, Sharon Babar, ... Muhammad Sajid Hamid Akash in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 July 2024
  16. DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer

    Increasing evidence indicates that DNA damage-induced apoptosis suppressor (DDIAS) is an oncogenic protein that is highly expressed in a variety of...

    Joo-Young Im, Mi-Jung Kang, ... Misun Won in Experimental & Molecular Medicine
    Article Open access 01 May 2023
  17. Singlet Anticancer Therapy Through Epi-Weapons Histone Deacetylase Inhibitors and Its Shortcomings

    Appalling toxicities and chemoresistance associated with conventional anticancer therapies raise applicability related concerns (Howard et al. 2016)....
    Chapter 2020
  18. Molecular Biomarkers of Cancer and Their Diagnostic Applications

    Cancer, characterized by abnormal cell growth, remains a significant global health concern. The intricate interplay of genetic, epigenetic, and...
    Aitizaz Ul Ahsan, Sweety Mehra, ... Mani Chopra in Molecular Biomarkers for Cancer Diagnosis and Therapy
    Chapter 2024
  19. The Role of Interleukin (IL)-6/IL-6 Receptor Axis in Cancer

    As a pleiotropic cytokine, interleukin (IL)-6 plays a key role in mediating the host’s immune defense. Multiple cell types are involved in IL-6...
    Manzoor Ahmad Mir, Masrat Bashir, Nusrat Jan in Cytokine and Chemokine Networks in Cancer
    Chapter 2023
  20. Phytochemicals in ROS-Mediated Epigenetic Modulation of Cancer

    It is a fundamental understanding in molecular biology that changes in DNA are reflected in transcription of aberrant messenger RNA (mRNA) and...
    Reference work entry 2022
Did you find what you were looking for? Share feedback.